Risk factor
Very high price volatility
Profitability factor
Greatly undervalued vs peers
About
Schwazze, formally known as Medicine Man Technologies, Inc., functions as a prominent cannabis enterprise. Its operations are structured across three primary divisions: Retail, Wholesale, and Other segments. The company offers a diverse product portfolio encompassing a comprehensive array of cannabis goods. This includes unprocessed flower, various concentrates, edible products, pre-rolled joints, topical applications, and other associated items, alongside vape cartridges and syringes. As of March 14, 2022, Schwazze managed a significant retail network. This consisted of 23 recreational cannabis dispensaries located throughout Denver and the wider Colorado region, operating under recognizable brand names such as Star Buds, Smoking Gun Apothecary, Emerald Fields, and Drift. Additionally, it operated 10 medical cannabis dispensaries in New Mexico, primarily recognized by the R. Greenleaf banner. Beyond its core product and retail ventures, Schwazze extends its services to include licensing, consulting, and expertise in facility design and management. It is also responsible for publishing the "Three A Light" guide. Furthermore, the company is engaged in the manufacturing, wholesale distribution, and retail sale of various plant nutrients specifically formulated for cannabis cultivation, complementing this with the provision of hydroponic and indoor gardening supplies. Established in 2014, the firm maintains its corporate headquarters in Denver, Colorado.
Company Valuation
Considering past and projected metrics, the stock is distinctly 'cheaper' than its peers. In particular, the stock is of fair value on EV/EBITDA, undervalued on P/FC.